查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1612126

脫髮症治療藥物市場：按疾病類型、給藥途徑、性別、治療選擇和最終用戶 - 全球預測 2025-2030

Alopecia Treatment Market by Disease Type (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Route of Administration (Injectable, Oral, Topical), Gender, Treatment Option, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年脫髮症治療藥物市場規模為48.5億美元，預計2024年將達到52.7億美元，複合年成長率為8.89%，預計到2030年將達到88.1億美元。

脫髮症治療市場的範圍和定義包括旨在對抗與脫髮症、雄性禿和其他頭皮疾病相關的脫髮的治療性介入和產品。脫髮對人的生活品質和自尊心產生的心理影響強調了這種治療的必要性。治療方法包括局部治療、內服藥物、植髮等外科手術以及富含血小板的血漿和雷射療法等新治療方法。最終使用領域主要包括皮膚科診所、美容中心和個人家庭使用者。關鍵的成長要素包括脫髮症治療意識的提高、治療技術的進步以及醫療保健支出的增加。值得注意的是，生技藥品的出現和基因治療研究和開發的活性化正在為市場參與者創造新的機會。潛在的機會在於透過個人化醫療方法和負擔得起的解決方案擴大新興市場的准入。

主要市場統計
基準年[2023] 48.5億美元
預測年份 [2024] 52.7億美元
預測年份 [2030] 88.1億美元
複合年成長率（%） 8.89%

然而，該市場面臨一些限制和挑戰，包括高昂的治療成本、不同的患者反應、潛在的副作用和監管障礙。此外，與美容護理相關的文化觀念和偏見也會抑制某些地區的成長。為了克服這些挑戰並推動成長，創新和研究正在推動開發更安全、更有效、副作用更少的治療方法，例如基於胜肽的治療方法和奈米療法等新的遞送機制。了解頭髮疾病遺傳基礎的尖端研究可能會進一步調整治療方案。市場動態是以競爭壓力和快速技術進步為特徵的動態市場，這意味著需要持續創新。公司可以透過投資研究合作以及與研究機構和醫療保健提供者建立策略夥伴關係來增強研發能力並擴大產品系列，從而獲得競爭優勢。

市場動態：快速發展的脫髮症治療市場的主要市場洞察

供需的動態交互作用正在改變脫髮症藥物市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 脫髮症和脫髮症的盛行率增加
    • 人們對除毛和植髮的認知不斷增強
    • 收入水準上升和醫療保健支出增加
  • 市場限制因素
    • 脫髮症治療缺乏報銷政策
  • 市場機會
    • 新脫髮症治療方法和藥物的出現
    • 增加並擴大對毛髮移植診所的投資
  • 市場挑戰
    • 關於某些脫髮症治療方法的有效性和副作用的問題

波特的五力：駕馭脫髮症藥物市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解脫髮症治療藥物市場的外部影響

外部宏觀環境因素在塑造脫髮症治療藥物市場的表現動態中起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解脫髮症治療藥物市場的競爭狀況

對脫髮症治療藥物市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣脫髮症治療市場供應商的績效評估

FPNV 定位矩陣是評估脫髮症治療藥物市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，描繪脫髮症治療市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，脫髮症治療藥物市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 脫髮症和脫髮症的發生率增加
      • 人們對脫髮症和移植的認知不斷提高
      • 收入水準上升和醫療費用上升
    • 抑制因素
      • 脫髮症治療缺乏報銷政策
    • 機會
      • 脫髮症新治療方法和藥物的出現
      • 增加毛髮移植診所的投資和擴張
    • 任務
      • 有關某些脫髮治療療法的功效和副作用的問題
  • 市場區隔分析
    • 疾病類型：對脫髮症和全脫髮症的有效治療方法的需求日益成長。
    • 最終使用者：方便且經濟高效的居家照護治療
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章脫髮症治療藥物市場：依疾病類型

  • 脫髮症
  • 全脫髮症
  • 全身性脫髮症
  • 雄性脫髮症
  • 疤痕脫髮症
  • 牽引性脫髮症

第7章脫髮症治療藥物市場：依給藥途徑

  • 可注射的
  • 口服
  • 話題

第8章脫髮症治療藥物市場性別

  • 女士
  • 男人

第9章按治療方案分類的脫髮症治療藥物市場

  • 美容治療
    • 頭髮纖維粉
    • 頭皮微色素沉著
  • 治療
    • 蒽甙
    • 皮質類固醇
    • JAK抑制劑
    • 胺基甲基葉酸
    • 局部免疫治療
  • 手術治療
    • 毛囊單位提取
    • 毛髮移植手術
    • 頭皮縮小治療

第10章脫髮症治療藥物市場：依最終用戶分類

  • 皮膚科診所
  • 居家照護環境

第11章 北美和南美脫髮症治療藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區脫髮症治療藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的脫髮症治療藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 禮來公司的Olumiant（Baricitinib ）在加拿大核准用於治療嚴重脫髮症
    • HopeMed 推進創新雄性激素基因療法治療脫髮症的 2 期臨床試驗
    • FDA核准輝瑞 LITFULO（ritrecitinib）用於治療重症患者脫髮症
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Aclaris Therapeutics, Inc.
  • AnaptysBio Inc.
  • Apira Science, Inc.
  • Apple Therapeutics Private Limited
  • Arcutis Biotherapeutics, Inc.
  • Biocon Limited
  • Cipla, Inc.
  • Daiichi Sankyo Inc.
  • DR. KURT WOLFF GMBH & CO. KG
  • Dr. Reddy's Laboratories Ltd
  • Eli Lilly and Company
  • Fagron NV
  • Follica, Inc.
  • HCell Inc.
  • iRestore Hair Growth System
  • KNOW Bio LLC
  • Merck & Co.
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • RepliCel Life Sciences Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd
  • Transitions Hair Pty Ltd.
  • Viviscal
Product Code: MRR-A339DAEFA47E

The Alopecia Treatment Market was valued at USD 4.85 billion in 2023, expected to reach USD 5.27 billion in 2024, and is projected to grow at a CAGR of 8.89%, to USD 8.81 billion by 2030.

The scope and definition of the alopecia treatment market encompass therapeutic interventions and products aimed at counteracting hair loss associated with conditions like alopecia areata, androgenetic alopecia, and other scalp disorders. The necessity for such treatments is underscored by the psychological impact of hair loss, which can significantly affect a person's quality of life and self-esteem. Applications include topical treatments, oral medications, surgical procedures like hair transplantation, and emerging therapies such as platelet-rich plasma and laser treatments. End-use segments primarily involve dermatology clinics, aesthetic centers, and individual home users. Key growth factors include rising awareness about alopecia treatments, advancements in treatment technologies, and increased healthcare expenditure. Notably, the advent of biologics and increased R&D in gene therapy present fresh opportunities for market players. Potential opportunities lie in personalized medicine approaches and expanding access in emerging markets through affordable solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 4.85 billion
Estimated Year [2024] USD 5.27 billion
Forecast Year [2030] USD 8.81 billion
CAGR (%) 8.89%

However, the market faces several limitations and challenges, including high treatment costs, variability in patient response, potential side effects, and regulatory hurdles. Additionally, cultural perceptions and stigmas associated with aesthetic treatments might impede growth in certain regions. To navigate these challenges and foster growth, innovation and research could focus on developing safer, more effective treatments with fewer side effects, such as peptide-based interventions and novel delivery mechanisms like nanotherapy. Cutting-edge research in understanding the genetic basis of hair disorders could further tailor treatment options. The alopecia treatment market is dynamic, characterized by competitive pressures and rapid technological advancements, suggesting a need for continuous innovation. Companies may gain a competitive edge by investing in collaborations and fostering strategic partnerships with research institutions and health care providers, thereby enhancing their R&D capabilities and expanding their product portfolios.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Alopecia Treatment Market

The Alopecia Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of androgenetic alopecia and alopecia areata diseases
    • Growing awareness about hair loss and transplantation
    • Rise in income levels and increased healthcare spending
  • Market Restraints
    • Lack of reimbursement policies for alopecia treatments
  • Market Opportunities
    • Emergence of new alopecia areata treatments and therapeutics
    • Rising investments and expansion of hair transplant clinics
  • Market Challenges
    • Issues associated with efficacy and side-effects related to some hair loss treatment therapies

Porter's Five Forces: A Strategic Tool for Navigating the Alopecia Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Alopecia Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Alopecia Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Alopecia Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Alopecia Treatment Market

A detailed market share analysis in the Alopecia Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Alopecia Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Alopecia Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Alopecia Treatment Market

A strategic analysis of the Alopecia Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Alopecia Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aclaris Therapeutics, Inc., AnaptysBio Inc., Apira Science, Inc., Apple Therapeutics Private Limited, Arcutis Biotherapeutics, Inc., Biocon Limited, Cipla, Inc., Daiichi Sankyo Inc., DR. KURT WOLFF GMBH & CO. KG, Dr. Reddy's Laboratories Ltd, Eli Lilly and Company, Fagron NV, Follica, Inc., HCell Inc., iRestore Hair Growth System, KNOW Bio LLC, Merck & Co., Pfizer Inc., Regeneron Pharmaceuticals, Inc., RepliCel Life Sciences Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd, Transitions Hair Pty Ltd., and Viviscal.

Market Segmentation & Coverage

This research report categorizes the Alopecia Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Disease Type, market is studied across Alopecia Areata, Alopecia Totalis, Alopecia Universalis, Androgenetic Alopecia, Cicatricial Alopecia, and Traction Alopecia.
  • Based on Route of Administration, market is studied across Injectable, Oral, and Topical.
  • Based on Gender, market is studied across Female and Male.
  • Based on Treatment Option, market is studied across Cosmetic Treatment, Medical Treatment, and Surgical Treatment. The Cosmetic Treatment is further studied across Hair Fiber Powders and Scalp Micropigmentation. The Medical Treatment is further studied across Anthralin, Corticosteroid, JAK Inhibitors, Methotrexate, and Topical Immunotherapy. The Surgical Treatment is further studied across Follicular Unit Extraction, Hair Transplant Surgery, and Scalp Reduction Treatment.
  • Based on End User, market is studied across Dermatology Clinics and Homecare Setting.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of androgenetic alopecia and alopecia areata diseases
      • 5.1.1.2. Growing awareness about hair loss and transplantation
      • 5.1.1.3. Rise in income levels and increased healthcare spending
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of reimbursement policies for alopecia treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of new alopecia areata treatments and therapeutics
      • 5.1.3.2. Rising investments and expansion of hair transplant clinics
    • 5.1.4. Challenges
      • 5.1.4.1. Issues associated with efficacy and side-effects related to some hair loss treatment therapies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Disease Type: Growing need for effective treatments for alopecia universalis and alopecia totalis
    • 5.2.2. End User: homecare treatments owing to their Convenience and cost-effectiveness
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Alopecia Treatment Market, by Disease Type

  • 6.1. Introduction
  • 6.2. Alopecia Areata
  • 6.3. Alopecia Totalis
  • 6.4. Alopecia Universalis
  • 6.5. Androgenetic Alopecia
  • 6.6. Cicatricial Alopecia
  • 6.7. Traction Alopecia

7. Alopecia Treatment Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Injectable
  • 7.3. Oral
  • 7.4. Topical

8. Alopecia Treatment Market, by Gender

  • 8.1. Introduction
  • 8.2. Female
  • 8.3. Male

9. Alopecia Treatment Market, by Treatment Option

  • 9.1. Introduction
  • 9.2. Cosmetic Treatment
    • 9.2.1. Hair Fiber Powders
    • 9.2.2. Scalp Micropigmentation
  • 9.3. Medical Treatment
    • 9.3.1. Anthralin
    • 9.3.2. Corticosteroid
    • 9.3.3. JAK Inhibitors
    • 9.3.4. Methotrexate
    • 9.3.5. Topical Immunotherapy
  • 9.4. Surgical Treatment
    • 9.4.1. Follicular Unit Extraction
    • 9.4.2. Hair Transplant Surgery
    • 9.4.3. Scalp Reduction Treatment

10. Alopecia Treatment Market, by End User

  • 10.1. Introduction
  • 10.2. Dermatology Clinics
  • 10.3. Homecare Setting

11. Americas Alopecia Treatment Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Alopecia Treatment Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Alopecia Treatment Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Lilly's Olumiant (Baricitinib) Authorized in Canada for Severe Alopecia Areata Treatment
    • 14.3.2. HopeMed Advances Phase II Clinical Trials for Innovative Androgenetic Alopecia Treatment
    • 14.3.3. FDA Approves Pfizer's LITFULO (Ritlecitinib) for Severe Alopecia Treatment
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Aclaris Therapeutics, Inc.
  • 3. AnaptysBio Inc.
  • 4. Apira Science, Inc.
  • 5. Apple Therapeutics Private Limited
  • 6. Arcutis Biotherapeutics, Inc.
  • 7. Biocon Limited
  • 8. Cipla, Inc.
  • 9. Daiichi Sankyo Inc.
  • 10. DR. KURT WOLFF GMBH & CO. KG
  • 11. Dr. Reddy's Laboratories Ltd
  • 12. Eli Lilly and Company
  • 13. Fagron NV
  • 14. Follica, Inc.
  • 15. HCell Inc.
  • 16. iRestore Hair Growth System
  • 17. KNOW Bio LLC
  • 18. Merck & Co.
  • 19. Pfizer Inc.
  • 20. Regeneron Pharmaceuticals, Inc.
  • 21. RepliCel Life Sciences Inc.
  • 22. Sun Pharmaceutical Industries Ltd.
  • 23. Teva Pharmaceutical Industries Ltd
  • 24. Transitions Hair Pty Ltd.
  • 25. Viviscal

LIST OF FIGURES

  • FIGURE 1. ALOPECIA TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ALOPECIA TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ALOPECIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ALOPECIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. ALOPECIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ALOPECIA TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ALOPECIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ALOPECIA TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TOTALIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA UNIVERSALIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY CICATRICIAL ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TRACTION ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY HAIR FIBER POWDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SCALP MICROPIGMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ANTHRALIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY JAK INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY METHOTREXATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY FOLLICULAR UNIT EXTRACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY HAIR TRANSPLANT SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SCALP REDUCTION TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY HOMECARE SETTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 139. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 147. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 162. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 163. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 179. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 187. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 194. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 195. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 205. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 211. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 212. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 213. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 219. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 220. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 227. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 228. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 229. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 235. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 236. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 243. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 244. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 245. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 251. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 252. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. ITALY ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 259. ITALY ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 260. ITALY ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 268. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 269. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 275. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 276. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 277. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 283. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 284. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 285. POLAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 291. POLAND ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 292. POLAND ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 293. QATAR ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 299. QATAR ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 300. QATAR ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 301. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 307. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 308. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 316. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 324. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 325. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 330. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 331. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 332. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 333. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 334. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 335. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 336. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 337. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 338. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 339. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 340. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 342. SWITZERLAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)

TABLE